Xu J, Hu H, Sun Y, Zhao Z, Zhang D, Yang L
Front Immunol. 2024; 15:1441017.
PMID: 39185424
PMC: 11342396.
DOI: 10.3389/fimmu.2024.1441017.
Wang Z, Hu D, Pei G, Zeng R, Yao Y
Front Immunol. 2023; 14:1288699.
PMID: 38130724
PMC: 10733527.
DOI: 10.3389/fimmu.2023.1288699.
Huang S, Kulatunge O, OSullivan K
Genes (Basel). 2023; 14(5).
PMID: 37239388
PMC: 10218028.
DOI: 10.3390/genes14051028.
Khan A, Sawant T, Deen Z, Humayun W, Humayun Y
Cureus. 2022; 14(9):e28746.
PMID: 36072784
PMC: 9440737.
DOI: 10.7759/cureus.28746.
Tamirou F, Houssiau F
J Clin Med. 2021; 10(4).
PMID: 33572385
PMC: 7916202.
DOI: 10.3390/jcm10040670.
Aetiology of Systemic Lupus Erythematosus.
HOLBOROW E
J R Coll Physicians Lond. 2019; 4(1):37-43.
PMID: 30667729
PMC: 5367161.
Immunopathology of lupus nephritis.
Anders H, Fogo A
Semin Immunopathol. 2014; 36(4):443-59.
PMID: 24402709
DOI: 10.1007/s00281-013-0413-5.
The pathogenesis of lupus nephritis.
Lech M, Anders H
J Am Soc Nephrol. 2013; 24(9):1357-66.
PMID: 23929771
PMC: 3752952.
DOI: 10.1681/ASN.2013010026.
Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown.
Yung S, Chan T
Clin Dev Immunol. 2012; 2012:139365.
PMID: 22761629
PMC: 3386553.
DOI: 10.1155/2012/139365.
Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury.
Ankeny D, Popovich P
Neuroscience. 2008; 158(3):1112-21.
PMID: 18674593
PMC: 2661571.
DOI: 10.1016/j.neuroscience.2008.07.001.
IgG subclass distribution of autoantibodies to DNA and to nuclear ribonucleoproteins in autoimmune diseases.
Zouali M, Jefferis R, EYQUEM A
Immunology. 1984; 51(3):595-600.
PMID: 6230310
PMC: 1454452.
Reaction of systemic lupus erythematosus antinative DNA antibodies with native DNA fragments from 20 to 1,200 base pairs.
Papalian M, Lafer E, Wong R, Stollar B
J Clin Invest. 1980; 65(2):469-77.
PMID: 6153184
PMC: 371385.
DOI: 10.1172/JCI109690.
[Clinical findings and prognosis of kidney manifestations in systemic lupus erythematosus].
Hartl W, Roos R, Genth E
Klin Wochenschr. 1970; 48(12):711-23.
PMID: 5524893
DOI: 10.1007/BF01497128.
Complement-fixing ability of antinuclear factors. Studies in adult and juvenile rheumatoid arthritis and systemic lupus erythematosus.
Cossio P, Arana R, Morteo O, Hubscher O, Roux E
Ann Rheum Dis. 1971; 30(6):640-4.
PMID: 5316115
PMC: 1005843.
DOI: 10.1136/ard.30.6.640.
Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis.
Vallota E, Forristal J, Spitzer R, Davis N, WEST C
J Clin Invest. 1971; 50(3):552-8.
PMID: 5101779
PMC: 291962.
DOI: 10.1172/JCI106524.
Immunoglobulin G subclass of human antinuclear antibodies.
Tojo T, Friou G, Spiegelberg H
Clin Exp Immunol. 1970; 6(1):145-51.
PMID: 4984586
PMC: 1712756.
Anti-lymphocytic antibody and autoimmune disease: a review.
DENMAN A
Clin Exp Immunol. 1969; 5(3):217-49.
PMID: 4980325
PMC: 1579119.
Autoimmunity in thermal injury: occurrence of rheumatoid factors, antinuclear antibodies and antiepithelial antibodies.
Quismorio F, Bland S, Friou G
Clin Exp Immunol. 1971; 8(5):701-11.
PMID: 4931853
PMC: 1712975.
Antinuclear factors and chronic articular inflammation.
Zvaifler N, Martinez M
Clin Exp Immunol. 1971; 8(2):271-8.
PMID: 4929777
PMC: 1712952.
Complement-fixing granulocyte-specific antinuclear factors in neutropenic cases of rheumatoid arthritis.
Wiik A, Munthe E
Immunology. 1974; 26(6):1127-34.
PMID: 4604253
PMC: 1423356.